Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 245

    1.

    Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.

    Broeks A, Braaf LM, Huseinovic A, Nooijen A, Urbanus J, Hogervorst FB, Schmidt MK, Klijn JG, Russell NS, Van Leeuwen FE, Van 't Veer LJ.

    Breast Cancer Res. 2007;9(2):R26.

    PMID:
    17428320
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    The spectrum of ATM missense variants and their contribution to contralateral breast cancer.

    Broeks A, Braaf LM, Huseinovic A, Schmidt MK, Russell NS, van Leeuwen FE, Hogervorst FB, Van 't Veer LJ.

    Breast Cancer Res Treat. 2008 Jan;107(2):243-8. Epub 2007 Mar 28.

    PMID:
    17393301
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

    Bernstein JL, Haile RW, Stovall M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein BS, Teraoka SN, Diep AT, Smith SA, Capanu M, Reiner AS, Liang X, Gatti RA, Concannon P; WECARE Study Collaborative Group.

    J Natl Cancer Inst. 2010 Apr 7;102(7):475-83. Epub 2010 Mar 19.

    PMID:
    20305132
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study.

    Mellemkjaer L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale AL, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD Jr; WECARE Study Collaborative Group, Bernstein JL.

    Br J Cancer. 2008 Feb 26;98(4):728-33. Epub 2008 Feb 5.

    PMID:
    18253122
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.

    Bernstein JL, Langholz B, Haile RW, Bernstein L, Thomas DC, Stovall M, Malone KE, Lynch CF, Olsen JH, Anton-Culver H, Shore RE, Boice JD Jr, Berkowitz GS, Gatti RA, Teitelbaum SL, Smith SA, Rosenstein BS, Børresen-Dale AL, Concannon P, Thompson WD; WECARE study.

    Breast Cancer Res. 2004;6(3):R199-214. Epub 2004 Mar 9.

    PMID:
    15084244
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

    Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; for the Institut Curie Breast Cancer Study Group.

    Eur J Cancer. 2005 Oct;41(15):2304-11. Epub 2005 Sep 1.

    PMID:
    16140006
    [PubMed - indexed for MEDLINE]
    7.

    Histopathological features of breast cancer in carriers of ATM gene variants.

    Balleine RL, Murali R, Bilous AM, Farshid G, Waring P, Provan P, Byth K, Thorne H; kConFab Investigators, Kirk JA.

    Histopathology. 2006 Nov;49(5):523-32.

    PMID:
    17064299
    [PubMed - indexed for MEDLINE]
    8.

    ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.

    Paglia LL, Laugé A, Weber J, Champ J, Cavaciuti E, Russo A, Viovy JL, Stoppa-Lyonnet D.

    Breast Cancer Res Treat. 2010 Jan;119(2):443-52. Epub 2009 Apr 29.

    PMID:
    19404735
    [PubMed - indexed for MEDLINE]
    9.

    Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk.

    Kaufmann WK, Filatov L, Oglesbee SE, Simpson DA, Lotano MA, McKeen HD, Sawyer LR, Moore DT, Millikan RC, Cordeiro-Stone M, Carey LA.

    Carcinogenesis. 2006 Dec;27(12):2519-27. Epub 2006 Jun 15.

    PMID:
    16777992
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.

    Kontorovich T, Cohen Y, Nir U, Friedman E.

    Breast Cancer Res Treat. 2009 Jul;116(1):195-200. Epub 2008 Jul 19.

    PMID:
    18642075
    [PubMed - indexed for MEDLINE]
    11.

    ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.

    Brunet J, Gutiérrez-Enríquez S, Torres A, Bérez V, Sanjosé S, Galceran J, Izquierdo A, Menéndez JA, Gumà J, Borràs J.

    Clin Genet. 2008 May;73(5):465-73. Epub 2008 Apr 2.

    PMID:
    18384426
    [PubMed - indexed for MEDLINE]
    12.

    Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

    Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC.

    JAMA. 2006 Mar 22;295(12):1379-88.

    PMID:
    16551709
    [PubMed - indexed for MEDLINE]
    13.

    Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.

    Hirsch AE, Atencio DP, Rosenstein BS.

    Breast Cancer Res Treat. 2008 Jan;107(1):139-44. Epub 2007 Feb 27.

    PMID:
    17333338
    [PubMed - indexed for MEDLINE]
    14.

    Identification of women with an increased risk of developing radiation-induced breast cancer.

    Cardis E, Hall J, Tavtigian SV.

    Breast Cancer Res. 2007;9(3):106.

    PMID:
    17617928
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.

    Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL.

    J Natl Cancer Inst. 2003 Mar 19;95(6):448-57.

    PMID:
    12644538
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.

    Broeks A, Russell NS, Floore AN, Urbanus JH, Dahler EC, van T Veer MB, Hagenbeek A, Noordijk EM, Crommelin MA, van Leeuwen FE, van T Veer LJ.

    Int J Radiat Biol. 2000 May;76(5):693-8.

    PMID:
    10866292
    [PubMed - indexed for MEDLINE]
    17.

    Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.

    Concannon P, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Teraoka SN, Diep TA, Jansen L, Atencio DP, Langholz B, Capanu M, Liang X, Begg CB, Thomas DC, Bernstein L, Olsen JH, Malone KE, Lynch CF, Anton-Culver H, Bernstein JL; Women's Environment, Cancer, and Radiation Epidemiology Study Collaborative Group.

    Cancer Res. 2008 Aug 15;68(16):6486-91.

    PMID:
    18701470
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.

    Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA.

    JAMA. 1998 Mar 25;279(12):922-9.

    PMID:
    9544766
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.

    Lindeman GJ, Hiew M, Visvader JE, Leary J, Field M, Gaff CL, Gardner RJ, Trainor K, Cheetham G, Suthers G, Kirk J.

    Breast Cancer Res. 2004;6(4):R401-7. Epub 2004 Jun 2.

    PMID:
    15217508
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

    Gynecol Oncol. 2005 May;97(2):457-67.

    PMID:
    15863145
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk